Showing results (21-30 of 43) with videos related to
Sort By:
Pageof 5
Bioanalysis|October 8, 2016
Development and validation of an IA-LC/MS method to quantitate active and total B-type natriuretic peptide in human plasmaDerek L Chappell, Anita Yh Lee, Harold S Bernstein, et al.Biomarkers in Medicine|April 4, 2013
Circulating miR-122 as a potential biomarker of liver diseaseOmar F Laterza, Mitchell G Scott, Philip W Garrett-Engele, et al.Bioanalysis|July 12, 2016
An evaluation of an aptamer for use as an affinity reagent with MS: PCSK9 as an example proteinVinita Gupta, Michael E Lassman, Thomas McAvoy, et al.Bioanalysis|August 27, 2014
Quantitation of human peptides and proteins via MS: review of analytically validated assaysDerek L Chappell, Michael E Lassman, Thomas McAvoy, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|June 5, 2016
The clinical utility of mass spectrometry based protein assaysMichael E Lassman, Thomas McAvoy, Derek L Chappell, et al.The Journal of Applied Laboratory Medicine|December 8, 2019
A Machine Learning Approach to Identify a Circulating MicroRNA Signature for Alzheimer DiseaseXuemei Zhao, John Kang, Vladimir Svetnik, et al.Clinical Biochemistry|December 7, 2005
Assessment of BNP and NT-proBNP in emergency department patients presenting with suspected acute coronary syndromesScott J Cameron, Gary B Green, C Nicole White, et al.Clinical Chemistry|July 22, 2006
Identification of novel brain biomarkersOmar F Laterza, Vijay R Modur, Dan L Crimmins, et al.Journal of Alzheimer'S Disease : JAD|August 13, 2014
A candidate plasma protein classifier to identify Alzheimer's diseaseXuemei Zhao, Serguei Lejnine, Jeffrey Spond, et al.Clinical Chemistry|February 26, 2014
Quantification of tau in cerebrospinal fluid by immunoaffinity enrichment and tandem mass spectrometryThomas McAvoy, Michael E Lassman, Daniel S Spellman, et al.Pageof 5